Guangdong Transtek Medical Electronics Co., Ltd

SZSE:300562.SZ

10.84 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 255.757247.955248.679276.214223.4222.037162.605225.11298.937280.674260.375544.789477.935432.724365.624489.7402.434284.438160.176267.726265.175193.946156.821242.342197.518191.613143.63220.422247.883226.564171.721204.425203.052206.988156.179193.43111.545126.849126.849101.006101.006
Cost of Revenue 166.02161.277158.012188.532146.507156.706118.943166.571229.472223.025193.648438.467389.15363.008292.744366.804301.48213.416120.711201.853206.131142.079119.101175.804144.937146.158107.34153.682185.05170.394122.952138.997131.505140.267105.202459.02980.29590.78590.78573.61373.613
Gross Profit 89.73786.67890.66787.68276.89365.33243.66258.53969.46657.64966.727106.32388.78569.71572.88122.897100.95471.02239.46565.87459.04551.86637.7266.53952.58145.45536.2966.74162.83356.1748.76965.42971.54766.72150.977-265.59931.2536.06436.06427.39227.392
Gross Profit Ratio 0.3510.350.3650.3170.3440.2940.2690.260.2320.2050.2560.1950.1860.1610.1990.2510.2510.250.2460.2460.2230.2670.2410.2750.2660.2370.2530.3030.2530.2480.2840.320.3520.3220.326-1.3730.280.2840.2840.2710.271
Reseach & Development Expenses 23.04722.5627.63228.46226.5926.72426.54736.830.96636.15333.01456.28832.36431.52428.97823.71427.12725.75519.92322.26817.12515.37413.90719.39413.58511.41312.01214.36511.51140.241059.346025.693037.545.82710.39910.39900
General & Administrative Expenses 0-10.26520.723-32.17341.7180.41415.129-34.8546.893-9.40116.143-34.07350.069-8.97717.394-21.17711.393-2.7588.902-24.68411.911-2.7769.054-18.62810.49-15.95319.979-75.95320.994-18.89725.78926.26725.735-15.5820.41463.94612.20712.28812.2889.5339.533
Selling & Marketing Expenses 028.37326.50122.00426.39212.79310.49116.86217.35911.76321.08753.99413.7069.60420.44846.96223.71511.73910.12824.07916.76915.78112.44921.38917.27320.05516.31723.05724.57739.61615.80724.66517.17921.76612.77253.0189.0027.7227.7224.6124.612
SG&A 47.64349.05247.224-10.16968.1113.20725.62-17.98864.2522.36237.2319.92163.7740.62737.84225.78535.1088.98119.03-0.60428.6813.00421.5032.7627.7634.10136.296-52.89645.57120.71941.59650.93242.9136.18533.186120.41821.20921.21821.21814.14514.145
Other Expenses 0-2.244-0.04-1.2651.996-2.108-0.037-3.4553.073-3.0860.018-3.207-0.0820.004-0.01-0.481-0.059-0.587-0.641-2.1450.5660.3210.465-5.0920.804-3.3342.2628.9890.729-1.8395.5666.1961.4532.0270.133-176.4070.630000
Operating Expenses 70.6973.85676.26663.04670.77564.63552.8166.99369.60759.07772.903125.9769.85957.04768.27688.93761.44848.19338.40453.39646.86845.91534.95551.06941.63542.57737.3550.53947.19679.4242.80452.3644.76647.90334.062-176.40721.81421.88221.88214.95314.953
Operating Income 19.04812.82213.9117.7567.45621.53-12.216-45.842-0.252.4162.561-31.11915.9154.72610.56318.20428.33619.4026.22710.0213.9099.5284.1859.91710.3344.2232.03315.54513.908-25.0997.92219.20427.04619.46517.60617.02313.30512.94412.94412.47312.473
Operating Income Ratio 0.0740.0520.0560.0640.0330.097-0.075-0.204-0.0010.0090.01-0.0570.0330.0110.0290.0370.070.0680.0390.0370.0520.0490.0270.0410.0520.0220.0140.0710.056-0.1110.0460.0940.1330.0940.1130.0880.1190.1020.1020.1230.123
Total Other Income Expenses Net -3.240.326-0.04-1.2650.031-0.143-0.037-3.4550.003-0.0170.018-3.207-0.0820.004-0.010.043-0.0590.415-0.641-2.1450.5660.3210.465-2.1220.8041.0442.2629.0070.581-1.8444.6296.6091.3471.9740.1218.1390.5781.6731.6730.4790.479
Income Before Tax 15.80821.31513.86916.4917.48721.387-12.253-49.297-0.2472.3992.579-34.32615.8334.73110.55318.24628.27719.8185.5867.87514.4759.8494.657.79511.1385.2674.29524.55314.637-26.94313.47625.81428.39421.43917.72825.16213.88214.61714.61712.95212.952
Income Before Tax Ratio 0.0620.0860.0560.060.0340.096-0.075-0.219-0.0010.0090.01-0.0630.0330.0110.0290.0370.070.070.0350.0290.0550.0510.030.0320.0560.0270.030.1110.059-0.1190.0780.1260.140.1040.1140.130.1240.1150.1150.1280.128
Income Tax Expense 0.2150.3211.1320.4120.7690.6520.081-3.758-2.036-2.1151.473-1.561-0.422-1.790.8391.8662.072-1.1361.2321.7611.590.6922.9111.2472.8210.3722.0214.132.724-2.2413.6462.2097.1031.6491.8922.9372.6981.851.851.881.88
Net Income 15.67821.18413.66619.1866.54920.73-12.098-41.2212.0555.5871.286-29.59617.9647.52212.97816.87428.06420.1775.0465.97413.069.5632.4676.4739.0085.3973.13820.68811.976-24.6539.8323.60521.2919.7915.83522.22411.18412.76712.76711.07211.072
Net Income Ratio 0.0610.0850.0550.0690.0290.093-0.074-0.1830.0070.020.005-0.0540.0380.0170.0350.0340.070.0710.0320.0220.0490.0490.0160.0270.0460.0280.0220.0940.048-0.1090.0570.1150.1050.0960.1010.1150.10.1010.1010.110.11
EPS 0.0720.0990.060.0890.0310.097-0.056-0.190.010.0260.01-0.140.0840.0350.070.090.150.0920.030.030.070.0620.010.0380.050.0290.020.0570.06-0.140.050.150.150.140.0340.160.0780.090.090.0830.083
EPS Diluted 0.0720.0990.060.0890.0310.097-0.056-0.190.010.0260.01-0.140.0840.0350.070.090.150.0920.030.030.070.0620.010.0380.050.0290.020.0570.06-0.140.050.150.150.140.0340.160.0780.090.090.0830.083
EBITDA 16.76429.72123.05326.3718.0730.978-2.593-38.1259.98310.55911.522-23.67225.699.30115.63917.92232.86124.88510.48613.77719.66914.2988.4677.79513.37310.7721.29632.91217.078-19.3698.337-490.63627.50422.25116.915-376.79510.46213.71713.71713.19813.198
EBITDA Ratio 0.0660.0820.0770.0820.0270.092-0.073-0.0790.0590.051-0.02-0.0450.0460.0210.020.0350.0740.0790.0310.0260.0710.057-0.0040.0310.0680.066-0.0260.1270.068-0.080.029-2.40.1350.1180.098-1.9480.0690.1080.1080.1310.131